Teleflex Incorporated
Could not find a ticker for this position, may be a filing error
A maker of single-use medical devices for hospitals and healthcare providers worldwide, Teleflex sells vascular, interventional, and surgical products under brands like Arrow catheters, EZ-IO intraosseous systems, QuikClot hemostats, and MANTA closure devices. It operates through Americas, EMEA, and Asia segments and employs thousands of people globally. In 2025 it acquired BIOTRONIK's Vascular Intervention business, adding coronary and peripheral devices like drug-coated balloons and stents.
3.875% bond due 08/01/2017
Granted 54.0K
Granted 9.9K
Granted 8.1K
Granted 13.8K
Granted 13.0K
Granted 5.7K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Granted 1.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Weidman Jason R.President and CEO, Director · 1 transaction | — | 54.0K | 54.0K | — | — |
| Logue Daniel V.CVP, General Counsel & Secty · 4 transactions | +58.8% | 25.0K | 9.9K | — | — |
| Hicks Cameron PCorp. VP & Chief HR Officer · 4 transactions | +64.5% | 19.4K | 8.1K | — | — |
| Deren JohnExecutive Vice President & CFO · 4 transactions | +280.3% | 18.1K | 13.8K | — | — |
| Winters JamesCorp VP, Mfg and Supply · 4 transactions | +213.7% | 17.8K | 13.0K | — | — |
| Randle Stuart ADirector · 4 transactions | -16.8% | 16.5K | 5.7K | — | — |
| Krakauer Andrew ADirector · 1 transaction | +15.5% | 8.3K | 1.1K | — | — |
| Haggerty Gretchen RDirector · 1 transaction | +17.3% | 7.4K | 1.1K | — | — |
| Duncan Candace HDirector · 1 transaction | +19.2% | 7.0K | 1.1K | — | — |
| Ryu JaewonDirector · 1 transaction | +29.2% | 4.8K | 1.1K | — | — |
| Patil Neena MDirector · 1 transaction | +41.5% | 3.7K | 1.1K | — | — |
| Tokich Michael JDirector · 1 transaction | — | 1.1K | 1.1K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.